← Eichor
Study identifier: NCT07677033 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study

Condition: Osteoporosis · Musculoskeletal Health · Sarcopenia  ·  Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Functional Muscle-Bone Incongruity Index (FKUI) is a novel approach developed to evaluate the relationship between muscle function and bone health. This prospective observational study aims to investigate the clinical applicability of FKUI, which combines handgrip strength, total hip bone mineral density (BMD), and lumbar-hip BMD discordance. Approximately 200 adult participants undergoing routine DXA assessment will be enrolled. The study will examine whether the combined evaluation of muscle function and bone health parameters provides a more comprehensive assessment of musculoskeletal status than individual measures alone.

This description comes directly from the study's public registry record.

Talk to the study team

Dilek Ün Oğuzhanasiltürk, MD  ·  +90 5056367184  ·  dilekunoguzhan@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, TurkeyKüçükçekmece, Istanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07677033